Read + Share
Cho BC, Kim DW, Spira AI, Gomez JE, et al. Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced
non-small cell lung cancer: a phase 1 trial. Nat Med 2023 Sep 14. doi: 10.1038/s41591-023-02554.
PMID: 37710001
|
 |
|
Cho BC, Kim DW, Spira AI, Gomez JE, et al. Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced
non-small cell lung cancer: a phase 1 trial. Nat Med 2023 Sep 14. doi: 10.1038/s41591-023-02554.
PMID: 37710001
|
|
|
|